Sanj K. Patel, CHAIRMAN & CEO at Kiniksa Pharmaceuticals International, plc (KNSA), sold 508,339 shares at $50.43 ($26.4M) on 2026-04-28, disclosed to the SEC on 2026-04-30.
Scheduled sale ($26.4M) by CHAIRMAN & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.43 | 74,635 | $3.8M | 14.2% |
| 2 | $51.47 | 113,673 | $5.9M | 22.1% |
| 3 | $52.02 | 243,596 | $12.7M | 48.0% |
| 4 | $54.02 | 51,750 | $2.8M | 10.6% |
| 5 | $54.01 | 22,544 | $1.2M | 4.6% |
| 6 | $54.01 | 2,141 |
| $116K |
| 0.4% |
| Total | $51.96 avg | 508,339 | $26.4M | 100% |
| Filing → |
| KNSA | SELL | 2025-10-22 | $20.0M | — | Filing → |
| KNSA | SELL | 2025-05-28 | $4.6M | — | Filing → |
| KNSA | SELL | 2025-05-22 | $127K | — | Filing → |